Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Review of Gastroenterology & Hepatology|September 24, 2022
Key factors for improving adenoma detection rateAlessandro Gubbiotti, Marco Spadaccini, Matteo Badalamenti, et al.Intestinal Research|August 2, 2021
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluationBrigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, et al.Clinical and Translational Gastroenterology|July 18, 2020
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort StudyBrigida Barberio, Fabiana Zingone, Renata D'Incà, et al.Journal of Clinical Gastroenterology|September 24, 2021
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional StudyCarla Marinelli, Fabiana Zingone, Maria Giovanna Lupo, et al.Scientific Reports|May 15, 2021
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originatorLinda Cingolani, Brigida Barberio, Fabiana Zingone, et al.Journal of Clinical Medicine|March 28, 2024
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's DiseaseLuisa Bertin, Brigida Barberio, Alessandro Gubbiotti, et al.Endoscopy International Open|May 16, 2025
Impact of age and comorbidities on colorectal endoscopic submucosal dissection outcomes: Large multicenter study in a Western cohortSandro Sferrazza, Giulio Calabrese, Marcello Maida, et al.Endoscopy|January 23, 2025
Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel diseaseRoberta Maselli, Roberto de Sire, Federico Barbaro, et al.Pageof 1